|
BAG2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.248300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.969200E-01 |
| Normal-vs-Stage2 |
1.303600E-01 |
| Normal-vs-Stage3 |
2.833000E-01 |
| Normal-vs-Stage4 |
6.879900E-02 |
| Stage1-vs-Stage2 |
9.807800E-02 |
| Stage1-vs-Stage3 |
3.806800E-01 |
| Stage1-vs-Stage4 |
7.839600E-02 |
| Stage2-vs-Stage3 |
7.655600E-01 |
| Stage2-vs-Stage4 |
1.935790E-01 |
| Stage3-vs-Stage4 |
1.542370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.886300E-02 |
| Normal-vs-AfricanAmerican |
4.964200E-01 |
| Normal-vs-Asian |
3.352200E-01 |
| Caucasian-vs-AfricanAmerican |
2.819600E-01 |
| Caucasian-vs-Asian |
4.648400E-01 |
| AfricanAmerican-vs-Asian |
3.807000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.920960E-01 |
| Normal-vs-Female |
5.092400E-02 |
| Male-vs-Female |
2.029400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.319000E-01 |
| Normal-vs-Extreme_Weight |
5.094800E-01 |
| Normal-vs-Obese |
1.923970E-01 |
| Normal-vs-Extreme_Obese |
3.944600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.912800E-01 |
| Normal_Weight-vs-Obese |
7.820600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.550800E-01 |
| Extreme_Weight-vs-Obese |
3.837800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.282400E-01 |
| Obese-vs-Extreme_Obese |
9.957400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.918000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.130040E-01 |
| Normal-vs-Age(61-80Yrs) |
1.728030E-01 |
| Normal-vs-Age(81-100Yrs) |
7.078800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.328200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.900600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.020800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.802400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.031600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.186600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.440400E-01 |
| Normal-VS-Type2 PRCC |
4.362900E-03 |
| Normal-VS-KIRP CIMP |
5.888000E-01 |
| Normal-VS-Unclassified PRCC |
6.416400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.016300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.923200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.348400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.349600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.169600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.051200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.961200E-01 |
| Normal-vs-N1 |
1.727750E-02 |
| Normal-vs-N2 |
3.493800E-01 |
| N0-vs-N1 |
4.066200E-02 |
| N0-vs-N2 |
1.463990E-01 |
| N1-vs-N2 |
8.387600E-01 |
|
|
